The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine ... prices of the originator insulin are around $329 per vial and $510 for five pens, according to ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

Merilog has been cleared in a 3ml single-patient-use prefilled pen, and a 10ml multiple-dose vial should be administered ... of Sanofi's basal insulin product Lantus (insulin glargine) – Viatris ...

Coverage of Lantus cartridges will continue to be available for pediatric patients who require a half-unit pen device to administer insulin glargine. Coverage of NovoRapid vials will continue to be ...

Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...

Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly ...

While long-acting insulin is slow to reach the bloodstream and has a relatively low peak, it stabilizes the “plateau” effect on blood sugar that can last most of the day. Glargine or Lantus is ...

A private pharmaceutical firm has donated five-thousand insulin vials to the Health Department for diabetic patients in Kurram. According to Secretary Health Adeel Shah, the firm handed over insulin ...